The case for aromatase inhibitors use in Oncofertility patients. Should aromatase inhibitors be combined with gonadotropin treatment in Breast Cancer patients undergoing ovarian stimulation for fertility preservation prior to chemotherapy? A debate

Abstract

Abstract is not available.

    Similar works

    Full text

    thumbnail-image

    Available Versions